0001415889-22-000748.txt : 20220125
0001415889-22-000748.hdr.sgml : 20220125
20220125160542
ACCESSION NUMBER: 0001415889-22-000748
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220121
FILED AS OF DATE: 20220125
DATE AS OF CHANGE: 20220125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Norkunas Matthew
CENTRAL INDEX KEY: 0001816836
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39319
FILM NUMBER: 22553977
MAIL ADDRESS:
STREET 1: C/O GENERATION BIO CO.
STREET 2: 301 BINNEY STREET, SUITE 401
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Generation Bio Co.
CENTRAL INDEX KEY: 0001733294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 814301281
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 857-529-5908
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
form4-01252022_040114.xml
X0306
4
2022-01-21
0001733294
Generation Bio Co.
GBIO
0001816836
Norkunas Matthew
C/O GENERATION BIO CO., 301 BINNEY ST
CAMBRIDGE
MA
02142
false
true
false
false
CHIEF FINANCIAL OFFICER
Stock Option (right to buy)
6.49
2022-01-21
4
A
0
119000
0
A
2032-01-21
Common Stock
119000
119000
D
Restricted Stock Units
2022-01-21
4
A
0
59500
0
A
Common Stock
59500
59500
D
This option was granted on January 21, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on January 21, 2023 and the remaining shares vesting in equal quarterly installments thereafter.
Each restricted stock unit represents the right to receive one share of the company's common stock.
The shares underlying the restricted stock units vest over two years, with 25% of the shares vesting on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.
/s/ Jennifer Elliott, Attorney-in-Fact
2022-01-25